NGVT Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
305.1M
-2.9%
314.1M
+21.7%
258.0M
+1.1%
255.1M
-23.4%
333.1M
Cost of Revenue
172.3M
-1.6%
175.1M
+23.7%
141.6M
-15.4%
167.3M
-16.0%
199.2M
Gross Profit
132.8M
-4.5%
139.0M
+19.4%
116.4M
+32.6%
87.8M
-34.4%
133.9M
Operating Expenses
50.4M
-32.0%
74.1M
+5.4%
70.3M
-56.3%
161.0M
+202.1%
53.3M
R&D
8.3M
+36.1%
6.1M
-9.0%
6.7M
-9.5%
7.4M
+5.7%
7.0M
SG&A
38.1M
-2.3%
39.0M
-4.2%
40.7M
-2.2%
41.6M
-5.7%
44.1M
Operating Income
82.4M
+27.0%
64.9M
+40.8%
46.1M
+163.0%
-73200000
-190.8%
80.6M
EBITDA
103.5M
-14.3%
120.7M
+74.2%
69.3M
+3.9%
66.7M
-39.1%
109.6M
Net Income
49.3M
+39.7%
35.3M
-41.0%
59.8M
+170.7%
-84600000
-294.5%
43.5M
EPS (Basic)
$1.44
+41.2%
$1.02
-40.0%
$1.70
+171.7%
$-2.37
-297.5%
$1.20
EPS (Diluted)
$1.41
+41.0%
$1.00
-39.8%
$1.66
+168.3%
$-2.43
-305.9%
$1.18
Shares (Diluted)
34.9M
-1.2%
35.3M
-2.1%
36.0M
+3.5%
34.8M
-5.8%
37.0M
Ingevity (NGVT) — Financials